Blog

A major milestone in cancer treatment could open a new chapter for patients with advanced stomach and gastroesophageal junction cancers.  OncLive.com at X.com. https://x.com/OncLive/status/2069074762161078737  A breakthrough beyond blood cancers  China has reached a major milestone in cancer care with the approval of satricabtagene autoleucel, commonly known as satri-cel—the first CAR-T cell therapy approved anywhere in the world for a solid […]

How three competing frameworks for measuring tumor response are reshaping the science — and the business — of cancer drug development   In the middle of a clinical trial, a radiologist looks at a scan and sees a tumor that has grown. Under the rules that have governed oncology research for decades, the conclusion would

Traumatic Brain Injury (TBI) is a significant public health concern, often leading to long-term physical, cognitive, and emotional impairments. While medical science has made considerable strides in understanding and managing TBI, effective treatments for reversing its effects remain elusive. Among the emerging therapies, Ibogaine, a naturally occurring alkaloid derived from the root bark of the

CRISPR technology has rapidly moved in the last few years and became one of the greatest scientific breakthroughs in recent times, in terms of crucial impact on genetic studies and processes. From their discovery in a bacterial immune pathway to a Genome Editor, starting from the bench till the clinical studies, the possible therapeutic use

Schizophrenia, a chronic and severe mental health disorder, affects approximately 1 in 100 people worldwide. Characterized by symptoms such as hallucinations, delusions, disorganized thinking, and emotional blunting, schizophrenia presents significant challenges both for patients and healthcare systems. Traditionally, antipsychotic medications have been the cornerstone of treatment, but many individuals continue to struggle with side effects

All about Lenacapavir, The Breakthrough Drug of 2024 In an unexpected turn events, Science named Lenacapavirn not just the breakthrough drug of 2024, but the breakthrough of 2024 across all domains of science and technology. What is it about this drug? Let’s find out. Lenacapavir represents a novel and promising advancement in the treatment of

Hemophilia is a rare but serious genetic disorder that impairs the blood’s ability to clot, leading to prolonged bleeding and frequent hemarthroses (joint bleeds). For individuals living with this condition, managing bleeding episodes is paramount to preventing complications such as joint damage and long-term disability. Over the past few years, new treatments have emerged to

From Pills to Circuits:  How Clinical Trials are pushing the frontier of migraine treatment Migraines are more than just headaches. They are complex neurological conditions that affect over one billion people worldwide, characterized by intense, throbbing pain, often accompanied by symptoms like nausea, sensitivity to light and sound, and visual disturbances. While the exact mechanisms

Aging is an inevitable biological process that affects every living organism. While aging is not a disease, it is accompanied by a decline in physiological functions and an increased risk of chronic illnesses, such as cardiovascular disease, cancer, diabetes, and neurodegenerative disorders. As global life expectancy increases, the need for clinical research focused on aging

Pulse Field Ablation (PFA) is a revolutionary technique in the field of cardiac electrophysiology, offering a safer and more precise method to treat arrhythmias, particularly atrial fibrillation (AF). By leveraging the principles of electroporation, PFA selectively targets cardiac tissue while sparing surrounding structures. This essay delves into the history of PFA, its current role in